Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ASTH Astrana Health	$21.57 -9.6%	$24.60	$21.43 ▼ $63.20	$1.34B	0.85	301,057 shs	638,034 shs
FLYW Flywire	$10.37 -4.8%	$11.12	$8.20 ▼ $23.40	$1.32B	1.28	2.10 million shs	2.81 million shs
GDRX GoodRx	$4.53 -5.4%	$4.58	$3.67 ▼ $8.94	$1.71B	1.24	1.06 million shs	696,837 shs
OOMA Ooma	$11.05 -2.9%	$12.58	$7.83 ▼ $17.00	$304.98M	1.21	149,784 shs	150,106 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ASTH Astrana Health	-9.60%	-7.31%	-12.49%	-33.61%	-58.88%
FLYW Flywire	-4.78%	-11.29%	-12.34%	+8.36%	-43.36%
GDRX GoodRx	-5.43%	-9.40%	-10.30%	-3.21%	-49.94%
OOMA Ooma	-2.77%	-7.34%	-15.00%	-11.97%	+5.94%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ASTH Astrana Health	3.3803 of 5 stars	3.3	2.0	1.7	1.7	3.1
FLYW Flywire	4.0308 of 5 stars	4.1	4.0	2.3	2.5	1.9
GDRX GoodRx	3.0398 of 5 stars	3.3	2.0	2.0	2.5	1.9
OOMA Ooma	2.2209 of 5 stars	3.4	2.0	1.2	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ASTH Astrana Health	2.67	Moderate Buy	$53.29	147.04% Upside
FLYW Flywire	2.27	Hold	$14.77	42.42% Upside
GDRX GoodRx	2.64	Moderate Buy	$6.55	44.49% Upside
OOMA Ooma	2.80	Moderate Buy	$17.63	59.50% Upside

Current Analyst Ratings Breakdown

Latest OOMA, ASTH, FLYW, and GDRX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/17/2025	FLYW Flywire	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$12.00 ➝ $13.00
7/17/2025	FLYW Flywire	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold	$12.00
6/23/2025	FLYW Flywire	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$17.00 ➝ $15.00
6/2/2025	FLYW Flywire	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$12.00
5/13/2025	GDRX GoodRx	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$6.00 ➝ $5.25
5/9/2025	GDRX GoodRx	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$6.00 ➝ $5.00
5/8/2025	FLYW Flywire	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$10.00 ➝ $12.00
5/7/2025	FLYW Flywire	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$20.00 ➝ $17.00
5/7/2025	FLYW Flywire	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$16.00 ➝ $13.00
5/2/2025	FLYW Flywire	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$29.00 ➝ $17.00

(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ASTH Astrana Health	$2.03B	0.59	$1.34 per share	16.08	$14.59 per share	1.48
FLYW Flywire	$492.14M	2.56	$0.16 per share	63.62	$6.57 per share	1.58
GDRX GoodRx	$792.32M	2.04	$0.30 per share	15.06	$1.89 per share	2.40
OOMA Ooma	$259.38M	1.18	$0.47 per share	23.75	$3.16 per share	3.50

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ASTH Astrana Health	$43.15M	$0.72	29.96	15.30	0.88	1.56%	4.90%	2.68%	8/7/2025 (Estimated)
FLYW Flywire	$2.90M	$0.04	259.25	41.48	2.41	0.97%	1.57%	1.15%	8/5/2025 (Estimated)
GDRX GoodRx	$16.39M	$0.08	56.63	25.17	2.13	3.57%	7.85%	3.91%	8/6/2025 (Estimated)
OOMA Ooma	-$6.90M	-$0.19	N/A	1,105.00	N/A	-1.89%	2.72%	1.54%	8/26/2025 (Estimated)

Latest OOMA, ASTH, FLYW, and GDRX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/26/2025	Q2 2026	OOMA Ooma	$0.20	N/A	N/A	N/A	$65.77 million	N/A
8/7/2025	Q2 2025	ASTH Astrana Health	$0.36	N/A	N/A	N/A	$639.13 million	N/A
8/6/2025	Q2 2025	GDRX GoodRx	$0.0991	N/A	N/A	N/A	$205.72 million	N/A
8/5/2025	Q2 2025	FLYW Flywire	-$0.05	N/A	N/A	N/A	$119.65 million	N/A
5/8/2025	Q1 2025	ASTH Astrana Health	$0.23	$0.14	-$0.09	$0.14	$628.11 million	$620.39 million
5/7/2025	Q1 2025	GDRX GoodRx	$0.04	$0.09	+$0.05	$0.03	$202.25 million	$202.97 million
5/6/2025	Q1 2025	FLYW Flywire	$0.01	$0.03	+$0.02	-$0.03	$124.18 million	$128.70 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ASTH Astrana Health	N/A	N/A	N/A	N/A	N/A
FLYW Flywire	N/A	N/A	N/A	N/A	N/A
GDRX GoodRx	N/A	N/A	N/A	N/A	N/A
OOMA Ooma	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ASTH Astrana Health	0.54	1.70	1.70
FLYW Flywire	0.08	2.02	2.02
GDRX GoodRx	0.74	5.23	5.23
OOMA Ooma	N/A	1.16	0.88

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ASTH Astrana Health	52.77%
FLYW Flywire	95.90%
GDRX GoodRx	63.77%
OOMA Ooma	80.42%

Insider Ownership

Company	Insider Ownership
ASTH Astrana Health	20.00%
FLYW Flywire	4.40%
GDRX GoodRx	4.53%
OOMA Ooma	9.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ASTH Astrana Health	1,900	56.06 million	44.85 million	Optionable
FLYW Flywire	1,250	121.56 million	116.21 million	Optionable
GDRX GoodRx	950	357.17 million	340.99 million	Optionable
OOMA Ooma	1,186	27.60 million	24.87 million	Optionable

OOMA, ASTH, FLYW, and GDRX Headlines

Recent News About These Companies

Ooma (NYSE:OOMA) Stock Crosses Below Fifty Day Moving Average - What's Next?

August 2 at 7:20 AM | marketbeat.com

One day only! Manam, Ooma, 8Cuts to host catering open house mixer

July 31 at 11:45 PM | rappler.comR

Analyzing AAP (OTCMKTS:AAPJ) and Ooma (NYSE:OOMA)

July 26, 2025 | americanbankingnews.com

2600Hz, an Ooma Company, Introduces Powerful New Desktop and Mobile Apps for Unified Communications

July 24, 2025 | finance.yahoo.com

Ooma (NYSE:OOMA) Shares Cross Below Fifty Day Moving Average - Here's Why

July 16, 2025 | marketbeat.com

Ooma: Foster dog to forever home

July 15, 2025 | kslnewsradio.comK

The Moment Group brings beloved brands Manam, Din Tai Fung, and more to SM City Cebu

July 8, 2025 | msn.com

Ooma Continues Path On Improving Fundamentals

June 25, 2025 | seekingalpha.com

Ooma, Inc. (NYSE:OOMA) Director Andrew H. Galligan Sells 12,407 Shares

June 25, 2025 | insidertrades.com

Ooma AirDial Elevates POTS Replacement for Large Organizations

June 18, 2025 | tmcnet.com

Ooma AirDial Powers POTS Replacement For Large Organizations Through Unmatched Remote Management Features

June 17, 2025 | businesswire.com

Ooma, Inc. (NYSE:OOMA) is largely controlled by institutional shareholders who own 60% of the company

June 11, 2025 | finance.yahoo.com

Ooma Approves Amendments to Equity Plans

June 10, 2025 | tipranks.com

SEIZE THE MOMENT | The Moment Group makes a grand entrance at SM City Cebu this June

June 9, 2025 | businessmirror.com.phB

Ooma chief accounting officer sells $64,425 in stock

June 8, 2025 | investing.com

Namrata Sabharwal Sells 3,428 Shares of Ooma, Inc. (NYSE:OOMA) Stock

June 4, 2025 | insidertrades.com

Wall Street Analysts Believe Ooma (OOMA) Could Rally 34.07%: Here's is How to Trade

June 2, 2025 | zacks.com

Analysts Conflicted on These Communication Services Names: fuboTV (FUBO) and Ooma (OOMA)

May 31, 2025 | theglobeandmail.com

SM, The Moment Group, to bring first-in-Cebu dining experience

May 31, 2025 | rappler.comR

Ooma reaffirms $267M–$270M FY2026 revenue target as AirDial partnership momentum accelerates

May 30, 2025 | msn.com

Ooma Reports Fiscal First Quarter 2026 Financial Results

May 30, 2025 | morningstar.comM

New MarketBeat Followers Over Time

Media Sentiment Over Time

OOMA, ASTH, FLYW, and GDRX Company Descriptions

Astrana Health NASDAQ:ASTH

$21.57 -2.29 (-9.60%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$22.12 +0.54 (+2.53%)

As of 08/1/2025 07:49 PM Eastern

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

Flywire NASDAQ:FLYW

$10.37 -0.52 (-4.78%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$10.64 +0.28 (+2.65%)

As of 08/1/2025 06:18 PM Eastern

Flywire Corporation, together with its subsidiaries, operates as a payments enablement and software company in the United States and internationally. Its payment platform and network, and vertical-specific software help clients to get paid and help their customers to pay. The company's platform facilitates payment flows across multiple currencies, payment types, and payment options, as well as provides direct connections to alternative payment methods, such as Alipay, Boleto, PayPal/Venmo, and Trustly. It serves education, healthcare, travel, and business to business organizations. The company was formerly known as peerTransfer Corporation and changed its name to Flywire Corporation in December 2016. Flywire Corporation was incorporated in 2009 and is headquartered in Boston, Massachusetts.

GoodRx NASDAQ:GDRX

$4.53 -0.26 (-5.43%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$4.57 +0.04 (+0.88%)

As of 08/1/2025 07:24 PM Eastern

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Ooma NYSE:OOMA

$11.05 -0.33 (-2.90%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$11.04 -0.01 (-0.05%)

As of 08/1/2025 04:10 PM Eastern

Ooma, Inc. provides communications services and related technologies for businesses and consumers in the United States and Canada. The company's products and services include Ooma Office, a cloud-based multi-user communications system for small and medium-sized businesses; Ooma Connect, which delivers fixed wireless internet connectivity; and Ooma Enterprise, a unified-communications-as-a-service (UCaaS) solution. It also provides Ooma AirDial, a plain old telephone service; PureVoice HD, a residential phone services; Ooma basic that provides unlimited personal calling within the United States; and Ooma Premier, a suite of advanced calling features on a monthly or annual subscription basis. In addition, the company offers Ooma Telo, a home communications solution designed to serve as the primary phone line in the home; Ooma Telo Air, a wireless Ooma Telo with built-in Wi-Fi and Bluetooth; and Ooma Telo LTE, which combines the Ooma Telo base station with the Ooma LTE Adapter and battery back-up. Further, it provides Ooma Mobile HD app that allows users to make and receive phone calls and access Ooma features and settings; 2600Hz provides business communication applications; Talkatone mobile app; and OnSIP, an UCaaS solutions. The company offers its products through direct sales, distributors, retailers, and resellers, as well as online and sale representatives. Ooma, Inc. was incorporated in 2003 and is headquartered in Sunnyvale, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time